| Nectar Lifescience Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532649 |
NSE Symbol : NECLIFE |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE023H01027 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 31.97 |
Market Cap(₹Cr) : 469.83 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 238.43 | 241.75 | 222.89 | 256.69 | 220.45 |
| Net Sales | 1,669.97 | 1,684.08 | 1,523.67 | 1,668.23 | 1,541.82 |
| Other Income | 4.99 | 14.58 | 43.18 | 11.32 | 3.79 |
| Stock Adjustments | -117.29 | 40.21 | 41.64 | -14.97 | -102.80 |
| Total Income | 1,557.67 | 1,738.87 | 1,608.49 | 1,664.58 | 1,442.81 |
| EXPENDITURE : | |||||
| Raw Materials | 1,250.72 | 1,242.45 | 1,200.84 | 1,207.32 | 1,052.82 |
| Power and Fuel Cost | 104.16 | 129.52 | 127.39 | 101.41 | 84.63 |
| Other Manufacturing Expenses | 59.25 | 55.30 | 44.88 | 45.09 | 44.16 |
| Selling and Administration Expenses | 71.17 | 61.38 | 61.01 | 66.82 | 72.00 |
| Miscellaneous Expenses | 3.33 | 2.37 | 1.32 | 1.90 | 31.04 |
| Employee Benefit Expenses | 93.61 | 81.71 | 75.14 | 71.91 | 70.55 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | -24.57 | 166.13 | 97.91 | 170.13 | 87.63 |
| Interest | 74.58 | 87.14 | 79.48 | 78.81 | 112.03 |
| Gross Profit | -99.15 | 78.99 | 18.43 | 91.32 | -24.40 |
| Depreciation | 62.39 | 60.72 | 59.12 | 56.97 | 60.25 |
| Profit Before Tax | -161.54 | 18.27 | -40.69 | 34.35 | -84.65 |
| Current Tax | -47.85 | 13.27 | -18.24 | 9.03 | -11.50 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Net Profit | -113.68 | 5.00 | -22.46 | 25.32 | -73.15 |
| Extraordinary Items | 0.02 | 0.18 | 40.51 | 9.41 | -25.41 |
| Adjusted Net Profit | -113.70 | 4.82 | -62.97 | 15.91 | -47.74 |
| Adjustment below Net Profit | 0.54 | -0.34 | 0.19 | 0.81 | 0.00 |
| Profit/Loss Balance carried down | 703.93 | 699.27 | 721.54 | 695.41 | 766.26 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 1.12 |
| P & L Balance carried down | 590.79 | 703.93 | 699.27 | 721.54 | 691.99 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | -5.07 | 0.22 | -1.00 | 1.13 | -3.26 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 42.63 | 47.68 | 47.47 | 48.46 | 47.30 |
| Book Value(Adj)-Unit Curr | 42.63 | 47.68 | 47.47 | 48.46 | 47.30 |